AIDS vaccine using gamma-2 herpesvirus as a vector to express lentiviral (AIDS virus) genes

Summary A novel vaccine strategy, using recombinant rhesus monkey rhadinovirus, a close relative to human herpesvirus 8, has been developed at the lab of Dr. Desrosiers. Testing in primates demonstrates protective immunity against SIV, with anti-SIV antibodies against the envelope glycoprotein are persistently expressed. Further testing in primates is under way.

Applications A HIV vaccine. For Further Information Please Contact the Director of Business Development Michal Preminger Email: [email protected] Telephone: (617) 432-0920

Inventor(s): Desrosiers, Ronald C.

Type of Offer: Licensing



« More Medical Patents

---